Vaccine Effectiveness Against Influenza Hospitalization and Emergency Department Visits in 2 A(H3N2) Dominant Influenza Seasons Among Children18 Years Old-New Vaccine Surveillance Network 2016-2017 and 2017-2018
- Resource Type
- Authors
- Sara S, Kim; Eric A, Naioti; Natasha B, Halasa; Laura S, Stewart; John V, Williams; Marian G, Michaels; Rangaraj, Selvarangan; Christopher J, Harrison; Mary A, Staat; Elizabeth P, Schlaudecker; Geoffrey A, Weinberg; Peter G, Szilagyi; Julie A, Boom; Leila C, Sahni; Janet A, Englund; Eileen J, Klein; Constance E, Ogokeh; Angela P, Campbell; Manish M, Patel; Monica, McNeal
- Source
- The Journal of infectious diseases. 226(1)
- Subject
- Adolescent
Influenza A Virus, H3N2 Subtype
Vaccination
virus diseases
Vaccine Efficacy
Hospitalization
Influenza B virus
Infectious Diseases
Influenza A Virus, H1N1 Subtype
Influenza Vaccines
Case-Control Studies
Influenza, Human
Immunology and Allergy
Humans
Seasons
Child
Emergency Service, Hospital
- Language
- ISSN
- 1537-6613
Studies have shown egg-adaptive mutations in influenza vaccine strains that might have impaired protection against circulating A(H3N2) influenza viruses during the 2016–2017 and 2017–2018 seasons. We used the test-negative design and multivariable models to assess vaccine effectiveness against influenza-associated hospitalization and emergency department visits among children (